BMS 140 857 Pill - white round, 11mm
Generic Name: dasatinib
Pill with imprint BMS 140 857 is White, Round and has been identified as Sprycel 140 mg. It is supplied by Bristol-Myers Squibb.
Sprycel is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 140 857
Sprycel
- Generic Name
- dasatinib
- Imprint
- BMS 140 857
- Strength
- 140 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-0857
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
titanium dioxide
Note: Inactive ingredients may vary.
More about Sprycel (dasatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (21)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
